BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23177734)

  • 1. [Brainstem metastasis from a prostate adenocarcinoma in the context of Muir-Torre syndrome].
    Aldave G; Pay E; Queipo F; Idoate MA; Guridi J
    Neurocirugia (Astur); 2013; 24(2):78-81. PubMed ID: 23177734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
    Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
    BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sebaceous tumors and Muir-Torre syndrome].
    Bourlond F; Cribier B; Lipsker D; Velter C
    Ann Dermatol Venereol; 2015; 142(6-7):456-9. PubMed ID: 25890836
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
    Ferlicot S
    Ann Pathol; 2017 Jun; 37(3):235-240. PubMed ID: 28522123
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostate carcinoma with squamous differentiation after combination endocrine therapy: a case report].
    Nagashima T; Niiro M; Hirayama K; Date S; Okihara K; Mukaisho K
    Hinyokika Kiyo; 2012 Aug; 58(8):457-60. PubMed ID: 23052274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy].
    Barbón JJ; González-Tuero J; Gay LL; Pérez-García FJ; Sampedro A
    Arch Soc Esp Oftalmol; 2007 Nov; 82(11):715-7. PubMed ID: 17979041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Sebaceous Neoplasms for DNA Mismatch Repair Proteins in Muir-Torre Syndrome.
    Pollinger TH; Kieliszak CR; Logemann N; Gratrix ML
    Skinmed; 2017; 15(4):259-264. PubMed ID: 28859734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple benign adnexal tumours: Anything but benign.
    McCarthy RL; Thomas CL; Isaacs F
    Australas J Dermatol; 2019 Aug; 60(3):234-236. PubMed ID: 30671930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.
    Arnold A; Payne S; Fisher S; Fricker D; Soloway J; White SM; Novelli M; MacDonald K; Mackay J; Groves R; Canham N
    Fam Cancer; 2007; 6(3):317-21. PubMed ID: 17323113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic Prostatic Adenocarcinoma in Patient With Muir-Torre Syndrome Misdiagnosed as Metastatic Sebaceous Carcinoma: Case Report and Systematic Literature Review.
    Cattelan L; Abi-Rafeh J; Brimo F; Kazan R; Redpath M; Chergui M
    Am J Dermatopathol; 2020 Sep; 42(9):700-705. PubMed ID: 32568842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The tip of the iceberg: multiple cutaneous sebaceous tumor in colon cancer. Muir-Torre syndrome--case report].
    Herr G; Szenes M; Hohl G; Vinkler ME; Tüske G; Horváth J; Nagy G; Tihanyi M; Széll M; Nagy N; Gasztonyi B
    Orv Hetil; 2015 Jun; 156(24):979-84. PubMed ID: 26051134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Metastases From Adenocarcinoma of the Prostate.
    Flores-Terry MÁ; Cruz-Conde de Boom R; García-Arpa M; de Lara-Simón IM
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):360. PubMed ID: 28823393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muir-Torre Syndrome With a Frame-shift Mutation in the MSH2 Gene: A Rare Case Report and Literature Review.
    Chen Q; Wang M; Xu Z; Wang M; Jin S; Tian S; Xiao S
    Int J Gynecol Pathol; 2020 Mar; 39(2):136-140. PubMed ID: 32039937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muir-Torre syndrome: a case report and review of the literature.
    Okan G; Vural P; Ince Ü; Yazar A; Uras C; Saruç M
    Turk J Gastroenterol; 2012 Aug; 23(4):394-8. PubMed ID: 22965514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sebaceous adenoma arising within an ovarian mature cystic teratoma in Muir-Torre syndrome.
    Smith J; Crowe K; McGaughran J; Robertson T
    Ann Diagn Pathol; 2012 Dec; 16(6):485-8. PubMed ID: 21684182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.
    Kleinerman R; Marino J; Loucas E
    Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
    Landis MN; Davis CL; Bellus GA; Wolverton SE
    J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.